Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at the time of discharge and communicating that result to the accepting nephrologist and the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
40
Measuring residual kidney function at the time of hospital discharge by timed urine collection (6-24 hours in duration), transmitting the results (urine volume, urea clearance, and creatinine clearance) to the accepting nephrologist and to the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.
The same timed urine collection will be collected at the time of hospital discharge as in the intervention arm, but in the control arm the results will not be transmitted to the accepting nephrologist or to the patient and no information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule will be transmitted. Instead, the research team will call the accepting nephrologist to alert them that this is an AKI-D patient that is being followed by the research team for recovery for up to 60 days.
University of California, San Francisco
San Francisco, California, United States
RECRUITINGFeasibility: The proportion of patients who complete the timed urine collection within seven days before discharge and are able to have the results successfully transmitted to the accepting nephrologist and patient.
Time frame: Baseline
Recruitment rate: Number of patients enrolled per month
Time frame: Total study duration, anticipated 2 years
Screening-to-recruitment ratio: Number of patients who meet inclusion criteria divided by the number of patients enrolled.
Time frame: Total study duration, anticipated 2 years
Number of post-discharge urine collections completed
Time frame: Study day 60
Proportion prescribed a <3x/wk hemodialysis schedule at any time within 60 days of hospital discharge
Time frame: Study day 60
Proportion who recover from needing dialysis
Time frame: Study day 60
Proportion who trial a <3x/wk hemodialysis schedule but subsequently need to be increased to >= 3x/wk during the 60-day follow-up.
Time frame: Study day 60
Incidence of adverse events
Time frame: Study day 60
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.